Reckweg JT

Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, MD 6200, the Netherlands.

14 papers · 2 preprints · ORCID

ArticleAyahuasca

Brain-body integromics of the ayahuasca experience.

Madrid-Gambin F, Mallaroni P, Haro N +7

Europe PMC2026
ArticleDMT

Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT.

Reckweg JT, Mason NL, Theunissen EL +3

Europe PMC2025
ArticlePsilocybin

Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.

Ramaekers JG, Reckweg JT, Mason NL

Europe PMC2025
ArticlePsychedelics

Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.

Ramaekers JG, Reckweg JT, Mason NL +3

Europe PMC2025
ArticleAyahuasca

Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study.

Doss MK, Kloft L, Mason NL +6

Europe PMC2025
ArticleAyahuasca

Shared functional connectome fingerprints following ritualistic ayahuasca intake.

Mallaroni P, Mason NL, Kloft L +6

Europe PMC2024
ArticleAyahuasca

Cortical structural differences following repeated ayahuasca use hold molecular signatures.

Mallaroni P, Mason NL, Kloft L +3

Europe PMC2023
ArticleAyahuasca

Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users.

Ramaekers JG, Mallaroni P, Kloft L +4

Europe PMC2023
ArticleDMT

A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression.

Reckweg JT, van Leeuwen CJ, Henquet C +6

Europe PMC2023
ArticlePsilocybin

Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition.

Mallaroni P, Mason NL, Reckweg JT +6

Europe PMC2023
PreprintPsilocybin

Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition

Mallaroni P, Mason NL, Reckweg JT +6

Europe PMC2023
PreprintAyahuasca

Ritualistic use of ayahuasca enhances a shared functional connectome identity with others

Mallaroni P, Mason NL, Kloft L +6

Europe PMC2022
ArticleAyahuasca

Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience.

Madrid-Gambin F, Gomez-Gomez A, Busquets-Garcia A +11

Europe PMC2022
ArticleDMT

The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).

Reckweg JT, Uthaug MV, Szabo A +4

Europe PMC2022
ArticlePsilocybin

Spontaneous and deliberate creative cognition during and after psilocybin exposure.

Mason NL, Kuypers KPC, Reckweg JT +7

Europe PMC2021
ArticleAyahuasca

A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.

Uthaug MV, Mason NL, Toennes SW +6

Europe PMC2021